271 research outputs found
Assessing the Effects of Time Budget and Traffic Density with the Help of a Trajectory-Planning Method
In"?tex id="Q1" staff-cmt="As per style âThe Nertherlandsâ in country name should not contain, hence we ignored the authors corrections. Please check and confirm."?" highly automated driving, the driver can engage in a nondriving task but sometimes has to take over control. We argue that current takeover quality measures, such as the maximum longitudinal acceleration, are insufficient because they ignore the criticality of the scenario. This paper proposes a novel method of quantifying how well the driver executed an automation-to-manual takeover by comparing human behaviour to optimised behaviour as computed using a trajectory planner. A human-in-the-loop study was carried out in a high-fidelity 6-DOF driving simulator with 25 participants. The takeover required a lane change to avoid roadworks on the ego-lane while taking other traffic into consideration. Each participant encountered six different takeover scenarios, with a different time budget (5âs, 7âs, or 20âs) and traffic density level (low or medium). Results showed that drivers exhibited a considerably higher longitudinal and lateral acceleration than the optimised behaviour, especially in the short time budget scenarios. In scenarios of medium traffic density, the trajectory planner showed a moderate deceleration to let a vehicle in the left lane pass; many participants, on the other hand, did not decelerate before making a lane change, resulting in a dangerous emergency brake of the left-lane vehicle. In conclusion, our results illustrate the value of assessing human takeover behaviour relative to optimised behaviour. Using the trajectory planner, we showed that human drivers are unable to behave optimally in urgent scenarios and that, in some conditions, a medium deceleration, as opposed to a maximal or minimal deceleration, is optimal.
Document type: Articl
Bevacizumab for metachronous metastatic colorectal cancer: A reflection of community based practice
Background: Although the efficacy of bevacizumab has been established in patients with metastatic colorectal cancer (mCRC), population-based studies are needed to gain insight into the actual implementation of bevacizumab in daily practice. Since these studies are lacking for patients with metachronous metastases, the aim of this study is to evaluate the current role of bevacizumab in the treatment of metachronous metastases of CRC. Methods: Data on the use of bevacizumab as palliative treatment of metachronous metastases were collected for patients diagnosed with M0 CRC between 2003 and 2008 in the Eindhoven Cancer Registry (n = 361). Median follow up was 5.3years. Results: One hundred eighty-five patients received bevacizumab in addition to first-line palliative chemotherapy (51%), ranging from 36% to 80% between hospitals of diagnosis (p < 0.0001). Combined cytostatic regimens (CAPOX/FOLFOX in 97%) were prescribed in the majority of patients (63%) and were associated with a higher odds for additional treatment with bevacizumab than single-agent cytostatic regimens (OR 9.9, 95% CI 5.51-18.00). Median overall survival (OS) rates were 21.6 and 13.9months with and without the addition of bevacizumab to palliative systemic treatment respectively (p < 0.0001). The addition of bevacizumab to palliative chemotherapy was associated with a reduced hazard ratio for death (HR 0.6, 95% CI 0.45-0.73) after adjustment for patient- and tumor characteristics and the prescribed chemotherapeutic regimen. Conclusion: Bevacizumab is adopted as a therapeutic option for metachronous metastasized CRC mainly in addition to first-line oxaliplatin-based regimens, and was associated with a reduced risk of death. The presence of inter-hospital differences in the prescription of bevacizumab reflected important differences in attitude and policies in clinical practice. Ongoing efforts should be made to further define the position of targeted agents in the treatment of metastatic colorectal cancer
How Does the Preparation of Rye Porridge Affect Molecular Weight Distribution of Extractable Dietary Fibers?
Extractable dietary fiber (DF) plays an important role in nutrition. This study on porridge making with whole grain rye investigated the effect of rest time of flour slurries at room temperature before cooking and amount of flour and salt in the recipe on the content of DF components and molecular weight distribution of extractable fructan, mixed linkage (1â3)(1â4)-β-d-glucan (β-glucan) and arabinoxylan (AX) in the porridge. The content of total DF was increased (from about 20% to 23% of dry matter) during porridge making due to formation of insoluble resistant starch. A small but significant increase in the extractability of β-glucan (P = 0.016) and AX (P = 0.002) due to rest time was also noted. The molecular weight of extractable fructan and AX remained stable during porridge making. However, incubation of the rye flour slurries at increased temperature resulted in a significant decrease in extractable AX molecular weight. The molecular weight of extractable β-glucan decreased greatly during a rest time before cooking, most likely by the action of endogenous enzymes. The amount of salt and flour used in the recipe had small but significant effects on the molecular weight of β-glucan. These results show that whole grain rye porridge made without a rest time before cooking contains extractable DF components maintaining high molecular weights. High molecular weight is most likely of nutritional importance
Technische aspecten, standaarden en richtlijnen m.b.t. EDI & Internet in de agrarische sector
Recommended from our members
Determination of the prebiotic activity of wheat arabinogalactan peptide (AGP) using batch culture fermentation
Purpose
To test the prebiotic activity of wheat arabinogalactan-peptide (AGP), which is a soluble dietary fibre composed of arabinogalactan polysaccharide linked to a 15-residue peptide, which accounts for up to 0.4% of the dry weight of wheat flour.
Methods
The prebiotic activity of AGP prepared from white wheat flour was tested using in-vitro fermentation by colonic bacteria in automated pH controlled anaerobic stirred batch cultures and compared to fructooligosaccharide (FOS) and wheat flour arabinoxylan (AX). Bacterial populations were measured using fluorescence in-situ hybridisation (flow-FISH) and short-chain fatty acid (SCFA) concentrations were measured using HPLC.
Results
Fermentation of AGP resulted in a significant bifidogenic activity and increased concentrations of SCFAs, mainly acetate after 24 h of fermentation.
Conclusions
These results were comparable to those obtained with AX and confirm the prebiotic potential of AGP. Furthermore, fermentation of a mixture of AGP and AX was faster compared to the single substrates and more similar to FOS, indicating that combinations of fermentable carbohydrates with different structures are potentially more effective as prebiotics than single substrates
Improvements in population-based survival of patients presenting with metastatic rectal cancer in the south of the Netherlands, 1992â2008
We analysed population-based treatment and survival data of patients who presented with metastatic rectal cancer. All patients diagnosed with primary synchronous metastatic rectal cancer between 1992 and 2008 in the Eindhoven Cancer Registry area were included. Date of diagnosis was divided into three periods (1992â1999, 2000â2004, 2005â2008) according to the availability of chemotherapy type. We assessed treatment patterns and overall survival according to period of diagnosis. The proportion of patients diagnosed with stage IV disease increased from 16% in 1992â1999 to 20% in 2005â2008 (PÂ <Â 0.0001). Chemotherapy use increased from 5% in 1992 to 61% in 2008 (PÂ <Â 0.0001). Resection rates of the primary tumour decreased from 65% in 1992 to 27% in 2008 (PÂ <Â 0.0001), while metastasectomy rates remained constant since 1999 (9%). Median survival increased from 38Â weeks (95% confidence interval (CI) 32â44) in 1992â1999 to 53Â weeks (95% CI 48â61) in 2005â2008. Among patients not receiving chemotherapy median survival remained approximately 30Â weeks. Multivariable analysis confirmed the lower risk of death among patients diagnosed in more recent years. Increased use of chemotherapy went together with improved median survival among patients with metastatic rectal cancer in the last two decades. Stage migration as an effect of more effective imaging procedures is likely to be partly responsible for this improved survival
Response to neoadjuvant chemotherapy and survival in molecular subtypes of resectable gastric cancer: : a post hoc analysis of the D1/D2 and CRITICS trials
Background Epstein-Barr virus positivity (EBV+) and microsatellite instability (MSI-high) are positive prognostic factors for survival in resectable gastric cancer (GC). However, benefit of perioperative treatment in patients with MSI-high tumors remains topic of discussion. Here, we present the clinicopathological outcomes of patients with EBV+, MSI-high, and EBV-/MSS GCs who received either surgery only or perioperative treatment. Methods EBV and MSI status were determined on tumor samples collected from 447 patients treated with surgery only in the D1/D2 trial, and from 451 patients treated perioperatively in the CRITICS trial. Results were correlated to histopathological response, morphological tumor characteristics, and survival. Results In the D1/D2 trial, 5-year cancer-related survival was 65.2% in 47 patients with EBV+, 56.7% in 47 patients with MSI-high, and 47.6% in 353 patients with EBV-/MSS tumors. In the CRITICS trial, 5-year cancer-related survival was 69.8% in 25 patients with EBV+, 51.7% in 27 patients with MSI-high, and 38.6% in 402 patients with EBV-/MSS tumors. Interestingly, all three MSI-high tumors with moderate to complete histopathological response (3/27, 11.1%) had substantial mucinous differentiation. No EBV+ tumors had a mucinous phenotype. 115/402 (28.6%) of EBV-/MSS tumors had moderate to complete histopathological response, of which 23/115 (20.0%) had a mucinous phenotype. Conclusions In resectable GC, MSI-high had favorable outcome compared to EBV-/MSS, both in patients treated with surgery only, and in those treated with perioperative chemo(radio)therapy. Substantial histopathological response was restricted to mucinous MSI-high tumors. The mucinous phenotype might be a relevant parameter in future clinical trials for MSI-high patients.Surgical oncolog
Bevacizumab for metachronous metastatic colorectal cancer: a reflection of community based practice
Carbon isotopes and lipid biomarkers from organic-rich facies of the Shuram Formation, Sultanate of Oman
- âŚ